Laboratory Corp Q3 2024 Adj. EPS $3.50 Beats $3.49 Estimate, Sales $3.282B Beat $3.260B Estimate
Portfolio Pulse from Benzinga Newsdesk
Laboratory Corp reported Q3 2024 adjusted EPS of $3.50, surpassing the estimate of $3.49. Sales reached $3.282 billion, also beating the expected $3.260 billion.
October 24, 2024 | 10:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Laboratory Corp's Q3 2024 earnings exceeded expectations with an adjusted EPS of $3.50 and sales of $3.282 billion, both surpassing analyst estimates.
The company's earnings and sales both exceeded analyst expectations, which is typically a positive indicator for stock performance. This suggests a strong financial position and could lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100